Investigating a new treatment for rheumatoid arthritis using POP2 peptides
POP2 as a novel therapeutic in rheumatoid arthritis
This study is looking at a protein called POP2 to see if it can help reduce inflammation and joint damage in people with rheumatoid arthritis, with the hope of finding new ways to manage symptoms without affecting the immune system.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Medical College NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project ID | NIH-10709887 on NIH RePORTER |
What this research studies
This research focuses on the role of a protein called POP2 in reducing inflammation associated with rheumatoid arthritis (RA). The study aims to test how POP2 and its derived peptides can be used to control inflammation and joint damage in a preclinical model of RA. By administering these peptides, researchers hope to inhibit key inflammatory pathways that contribute to the disease. The findings could lead to new treatment options that effectively manage RA symptoms without compromising the immune system.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rheumatoid arthritis who are experiencing significant inflammation and joint damage.
Not a fit: Patients who do not have rheumatoid arthritis or those whose condition is not primarily driven by inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel therapeutic option for patients suffering from rheumatoid arthritis, potentially reducing inflammation and improving joint health.
How similar studies have performed: Previous studies have shown promising results with similar approaches targeting inflammatory pathways, suggesting potential for success in this novel application.
Where this research is happening
Albany, United States
- Albany Medical College — Albany, United States (Active)
Researchers
- Principal investigator: Harton, Jonathan a — Albany Medical College
- Study coordinator: Harton, Jonathan a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.